Startseite UR

Ex vivo/in vitro absorption of STW 5 (Iberogast) and its extract components

Kelber, O., Wittwer, A., Lapke, C., Kroll, U., Weiser, D., Okpanyi, S. N. und Heilmann, Jörg (2006) Ex vivo/in vitro absorption of STW 5 (Iberogast) and its extract components. Phytomedicine 13 (Suppl.), S. 107-113.

Im Publikationsserver gibt es leider keinen Volltext zu diesem Eintrag.


Zusammenfassung

To correlate the pharmacol. effects of the fixed herbal combination STW 5 (Iberogast) contg. nine ext. components with its confirmed clin. efficacy, ex vivo/in vitro absorption tests were performed. For the investigation, the everted gut sac technique and, in a pilot study, the Caco-2-cell model were used. The absorption rate of the exts. was detd. by measuring characteristic marker substances of ...

plus


Bibliographische Daten exportieren



Dokumentenart:Artikel
Datum:2006
Zusätzliche Informationen (Öffentlich):CAN 146:394269 1-2 Pharmacology 99-49-0 (Carvone) Role: PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (Iberogast contg. Carum carvi ext. carvone showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell); 99-32-1 (Chelidonic acid) Role: PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (Iberogast contg. Chelidonium majus ext. chelidonic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell); 1405-86-3 (Glycyrrhizic acid) Role: PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (Iberogast contg. Glycyrhiza glabra ext. glycyrrhizic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell); 554-88-1 (Glucoiberin); 2222-07-3; 18444-66-1 (Cucurbitacine E) Role: PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (Iberogast contg. Iberis amara ext. glucoberin, cucurbitamine E and I showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell); 371973-50-1 (Iberogast) Role: NPO (Natural product occurrence), PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), USES (Uses) (Iberogast contg. Iberis, Matricaria, Carum, Silybum, Melissa, Mentha, Chelidonium, Glycyrhiza, Angelicae ext. showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell); 22567-36-8 (Bisabololoxide A) Role: PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (Iberogast contg. Matricaria reticulata ext. bisabololoxide A showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell); 20283-92-5 (Rosmarinic acid) Role: PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (Iberogast contg. Melissa officinalis ext. rosamarinic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell); 1490-04-6 (Menthol) Role: PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (Iberogast contg. Mentha piperita ext. menthol showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell); 22888-70-6 (Silibinin) Role: PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (Iberogast contg. Silybum marianum ext. silibinin showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell)
Institutionen:Chemie und Pharmazie > Institut für Pharmazie > Lehrstuhl Pharmazeutische Biologie (Prof. Heilmann)
Identifikationsnummer:
WertTyp
2007:280058Andere
Stichwörter / Keywords:Angelica archangelica (Iberogast contg. Angelicae radix ext. showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Carum carvi (Iberogast contg. Carum carvi ext. carvone showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Chelidonium majus (Iberogast contg. Chelidonium majus ext. chelidonic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Glycyrrhiza glabra (Iberogast contg. Glycyrhiza glabra ext. glycyrrhizic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Iberis amara (Iberogast contg. Iberis amara ext. glucoberin, cucurbitamine E and I showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Bioavailability Human (Iberogast contg. Iberis, Matricaria, Carum, Silybum, Melissa, Mentha, Chelidonium, Glycyrhiza, Angelicae ext. showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Matricaria chamomilla (Iberogast contg. Matricaria reticulata ext. bisabololoxide A showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Melissa officinalis (Iberogast contg. Melissa officinalis ext. rosamarinic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Mentha piperita (Iberogast contg. Mentha piperita ext. menthol showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Silybum marianum (Iberogast contg. Silybum marianum ext. silibinin showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Adenocarcinoma Colon neoplasm (colon adenocarcinoma Iberogast contg. Iberis, Matricaria, Carum, Silybum, Melissa, Mentha, Chelidonium, Glycyrhiza, Angelicae ext. showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Iberogast natural pharmaceutical absorption bioavailability colon adenocarcinoma
Dewey-Dezimal-Klassifikation:500 Naturwissenschaften und Mathematik > 570 Biowissenschaften, Biologie
500 Naturwissenschaften und Mathematik > 540 Chemie
Status:Veröffentlicht
Begutachtet:Ja, diese Version wurde begutachtet
An der Universität Regensburg entstanden:Ja
Eingebracht am:18 Okt 2010 12:56
Zuletzt geändert:08 Mrz 2017 08:27
Dokumenten-ID:17228
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
  1. Universität

Universitätsbibliothek

Publikationsserver

Kontakt:

Publizieren: oa@ur.de

Dissertationen: dissertationen@ur.de

Forschungsdaten: daten@ur.de

Ansprechpartner